APA (7th ed.) Citation

KP, C., ST, H., JS, P., J, R., E, S., E, S., . . . DP, N. (2014). Phase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women. Antimicrobial agents and chemotherapy, 58(4), 2113. https://doi.org/10.1128/AAC.02036-13

Chicago Style (17th ed.) Citation

KP, Connors, Housman ST, Pope JS, Russomanno J, Salerno E, Shore E, Redican S, and Nicolau DP. "Phase I, Open-label, Safety and Pharmacokinetic Study to Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women." Antimicrobial Agents and Chemotherapy 58, no. 4 (2014): 2113. https://doi.org/10.1128/AAC.02036-13.

MLA (9th ed.) Citation

KP, Connors, et al. "Phase I, Open-label, Safety and Pharmacokinetic Study to Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women." Antimicrobial Agents and Chemotherapy, vol. 58, no. 4, 2014, p. 2113, https://doi.org/10.1128/AAC.02036-13.